Subba Gollamudi, MD
Ophthalmology · Memphis, TNNPI 1154378735
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.0%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Johnson & Johnson Surgical Vision, Inc. at 55.7% of the total. Reporting peaked in 2019 at $22,487 and has fallen 86.8% since, to $2,958 in 2025. Among ophthalmology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 567 payments — averaging $118.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$37K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$12K
- Eyepoint US, Inc.$3K
- Alcon$3K
- Ocular Therapeutix, Inc.$2K
- Glaukos Corporation$2K
- plus $9K from 25 others
Across 12 payments — averaging $2716.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sun Pharmaceutical Industries Inc.$19K
- Eyepoint US, Inc.$14K
What the payments were for
- Consulting fees$35,67453%
- Speaking & faculty fees$10,55416%
- Travel & lodging$2,2453%
- Food & beverage$18,71628%
- Education$600%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 172 | $37,448 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 36 | $11,576 |
| Eyepoint US, Inc. | 19 | $2,957 |
| Alcon | 59 | $2,576 |
| Ocular Therapeutix, Inc. | 25 | $1,988 |
| Glaukos Corporation | 24 | $1,963 |
| Sun Pharmaceutical Industries Inc. | 4 | $1,651 |
| Bausch & Lomb Americas Inc. | 16 | $1,036 |
| Mallinckrodt Hospital Products Inc. | 33 | $892 |
| Kala Pharmaceuticals, Inc. | 47 | $799 |
| Harrow Eye, LLC | 11 | $789 |
| AbbVie(2 entities) | 34 | $780 |
| Biotissue Holdings Inc. | 13 | $511 |
| Rxsight Inc | 15 | $463 |
| Novartis | 17 | $358 |
| Amgen(2 entities) | 7 | $271 |
| Eyevance Pharmaceuticals LLC | 4 | $195 |
| Dompe US, Inc. | 5 | $155 |
| NEW World Medical,inc. | 3 | $143 |
| Thea Pharma Inc. | 2 | $127 |
| Johnson & Johnson Vision Care, Inc. | 1 | $87 |
| Oyster Point Pharma, Inc. | 5 | $84 |
| Dutch Ophthalmic, USA | 1 | $83 |
| ANI Pharmaceuticals, Inc. | 3 | $72 |
| Notal Vision, Inc. | 1 | $54 |
| Aerie Pharmaceuticals, Inc. | 3 | $50 |
| Shire North American Group Inc | 2 | $47 |
| Carl Zeiss Meditec, Inc. | 2 | $43 |
| Rayner Intraocular Lenses Limited | 1 | $21 |
| Tarsus Pharmaceuticals, Inc. | 1 | $18 |
| Omeros Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis IOL$24,249
- LOTEMAX SM$9,941
- Catalys Laser System$6,221
- Baerveldt Glaucoma Implants$6,000
- COMPACT INTUITIV Phacofragmentation System$6,000
- Compound/Component$6,000
- Tecnis Simplicity$4,257
- DEXTENZA$2,775
- DEXYCU$2,621
- CATALYS SYSTEM$2,114
- Tecnis Symfony IOL$1,620
- Tecnis Multifocal Family of 1-piece IOLS$1,618
- BROMSITE$1,608
- Tecnis 1-piece IOL$1,500
- VERITAS Vision System$936
- Clareon$509
- enVista MX60 IOL$485
- Photrexa$473
- VEVYE$419
- BESIVANCE$413
How this compares
$67,249 in reported general payments places this provider in the 95th percentile of 323 ophthalmology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 1,497 | $52,210 |
| MoxifloxacinMoxifloxacin Hcl | 1,066 | $26,446 |
| RestasisCyclosporine | 15 | $20,741 |
| LumiganBimatoprost | 34 | $15,986 |
| CombiganBrimonidine Tartrate/Timolol | 30 | $12,965 |
| Diclofenac Sodium | 1,063 | $12,374 |
| Loteprednol Etabonate | 52 | $7,108 |
| Cyclosporine | 14 | $5,322 |
| Trifluridine | 16 | $2,744 |
| ValacyclovirValacyclovir Hcl | 45 | $1,857 |
| Ketorolac Tromethamine | 82 | $1,808 |
| Brimonidine Tartrate | 34 | $1,084 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 11 | $1,067 |
| Acyclovir | 35 | $929 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 23 | $720 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan | $780 | $49,69379 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $11,576 | $7,10852 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 323 ophthalmology providers in Tennessee.
Other ophthalmology in Memphis
- Melissa ToyosMemphis$1.3M
- Rolando ToyosMemphis$809K
- Brian FowlerMemphis$206K
- Brian JerkinsMemphis$150K
- James FreemanMemphis$141K
- John FreemanMemphis$136K
- Penny AsbellMemphis$131K
- Kourtney HouserMemphis$104K
- Andrew CrothersMemphis$13K
- Brian SmithMemphis$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.